Wegovy (Semaglutide): Uses, Benefits, Dosage, and Safety Information

Wegovy (semaglutide) is a prescription medication used for long-term weight management in eligible patients. It can help reduce excess body weight when combined with a reduced-calorie diet and increased physical activity. Certain Wegovy formulations are also approved to reduce the risk of serious cardiovascular problems in eligible adults.

If you are researching Wegovy for weight management, this guide explains how it works, its potential benefits, how it is taken, and what you should know before starting treatment.

What Is Wegovy?

Wegovy is a brand-name medication that contains semaglutide. It belongs to a group of medicines called GLP-1 receptor agonists.

These medicines act on receptors involved in appetite regulation and blood sugar control. Wegovy can help people feel full for longer and reduce hunger, which may make it easier to manage food intake.

Wegovy is available in injectable and oral tablet formulations in the United States. The approved uses, dosing instructions, and safety considerations can differ between formulations.

Important: Wegovy is a prescription medicine. A qualified healthcare professional must determine whether it is appropriate for you.

What Are the Benefits of Wegovy?

When prescribed to eligible patients, Wegovy may offer several health benefits.

1. Supports Long-Term Weight Management

Wegovy can help reduce excess body weight and maintain weight reduction over time. It works best as part of a comprehensive weight-management plan that includes healthy eating and physical activity.

2. Helps Regulate Appetite

Semaglutide acts on pathways involved in hunger and fullness. Some people experience reduced appetite, fewer cravings, and greater satisfaction after eating.

Individual responses vary, and results are not guaranteed.

3. May Reduce Cardiovascular Risk

Injectable Wegovy is approved to reduce the risk of major cardiovascular events, including cardiovascular death, nonfatal heart attack, and nonfatal stroke, in certain adults with established cardiovascular disease who also have obesity or overweight.

This benefit applies to eligible patients and should not be interpreted as a guarantee against heart disease.